On the other hand, Gal-9 suppresses immune cells in the TME, thus favoring PDA progression as revealed by its co-expression with protumorigenic cytokines, like IL-10 or IL-17, as well as PD-L1 by γδ T cells [195]. This evidence concerns the gene LGALS9 and Patent ductus arteriosus.